Lemus, Stapel each rack up another retraction

The retraction counts keep mounting for two Retraction Watch frequent flyers. First, Diederik Stapel’s 26th retraction, according to our count. Psychologist Stapel admitted to making up data in dozens of studies, and is also facing a criminal inquiry for misuse of funds. Here’s the notice:

Most retraction notices don’t involve research misconduct or flawed data: new study

October, apparently, is “studies of retractions month.” First there was a groundbreaking study in PNAS, then an NBER working paper, and yesterday PLoS Medicine alerted us to a paper their sister journal, PLoS ONE, published last week, “A Comprehensive Survey of Retracted Articles from the Scholarly Literature.” The study, by Michael L. Grieneisen and Minghua Zhang, … Continue reading Most retraction notices don’t involve research misconduct or flawed data: new study

Feeling sheepish: Another retraction for Lemus, of study of whether livestock can spread chlamydia to birds

Jesús A. Lemus, the Spanish veterinary researcher whose work has been the subject of a misconduct inquiry, has another retraction for his CV. It’s his third, according to our count. The newest retraction is from PLoS ONE:

Walk (back) an Egyptian (vulture): Another paper by Spanish vet under scrutiny retracted

With apologies to the Bangles for this post’s title, we have another vulture-related retraction from Jesús A. Lemus, the Spanish veterinary researcher whose results have come into question. This one involves a paper that appeared in PLoS ONE in 2009, titled “Susceptibility to Infection and Immune Response in Insular and Continental Populations of Egyptian Vulture: … Continue reading Walk (back) an Egyptian (vulture): Another paper by Spanish vet under scrutiny retracted

Catching up: PLoS Pathogens apologizes for retracting XMRV-prostate cancer paper before contacting a corresponding author

Last week was a bit of a whirlwind in Retraction Land, thanks to a big study of retractions in PNAS and a lot of resulting press coverage. So we didn’t have a chance to update readers on an ongoing story and discussion involving the PLoS journals. As ScienceInsider was first to report last week, the … Continue reading Catching up: PLoS Pathogens apologizes for retracting XMRV-prostate cancer paper before contacting a corresponding author

Majority of retractions are due to misconduct: Study confirms opaque notices distort the scientific record

A new study out in the Proceedings of the National Academy of Sciences (PNAS) today finds that two-thirds of retractions are because of some form of misconduct — a figure that’s higher than previously thought, thanks to unhelpful retraction notices that cause us to beat our heads against the wall here at Retraction Watch. The … Continue reading Majority of retractions are due to misconduct: Study confirms opaque notices distort the scientific record

Immunology paper retracted because “documents were not archived with due diligence”

A group of researchers from Austria, Canada, Germany, and the U.S. have retracted a 2008 paper in the Journal of Immunology after being unable to verify the contents of some key figures. Here’s the notice:

Another XMRV shoe drops: PLoS Pathogens study linking prostate cancer to virus retracted

Less than 24 hours after the publication of a study showing no link between XMRV, aka xenotropic murine leukemia-related virus, and chronic fatigue syndrome (CFS), the authors of a a study claiming a link between the virus and prostate cancer have has been retractedit. The move comes along with the publication of a new study … Continue reading Another XMRV shoe drops: PLoS Pathogens study linking prostate cancer to virus retracted

Leading cancer vaccines researcher retracts paper for figure “discrepancies” flagged by watchdog blog

Gerold Schuler, a German immunology researcher who shared the 2006 Deutscher Krebspreis — aka the German Cancer Prize — for his work that contributed to cancer vaccines has retracted a paper in International Immunology following concerns raised by a German science watchdog blog. Here’s the notice:

Whistleblower forces retractions of four stem cell papers amid questions about more than a dozen studies

In a case that is a good reminder of why journal editors shouldn’t ignore anonymous tips, a Seoul National University stem cell researcher has been forced to retract four papers, and withdraw another under peer review, in Antioxidants & Redox Signaling following a whistleblower’s exhaustive analysis. Two retractions by Soo Kyung Kang, a professor of … Continue reading Whistleblower forces retractions of four stem cell papers amid questions about more than a dozen studies